Ed Arce
Stock Analyst at H.C. Wainwright
Total Price Targets
15
Stocks Covered
10
Sectors
Healthcare
Most Recent
Dec 30, 2024
Stocks Covered by Ed Arce
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| NAMS | NewAmsterdam Pharma Company N.V. | $48.00 | $28.65 | +67.5% | 1 | Dec 30, 2024 |
| RARE | Ultragenyx Pharmaceutical Inc. | $95.00 | $24.79 | +283.3% | 1 | Nov 6, 2024 |
| TVTX | Travere Therapeutics, Inc. | $18.00 | $44.19 | -59.3% | 3 | Sep 27, 2024 |
| PLRX | Pliant Therapeutics, Inc. | $38.00 | $1.23 | +3002.0% | 2 | Sep 13, 2024 |
| AUPH | Aurinia Pharmaceuticals Inc. | $13.00 | $15.46 | -15.9% | 1 | Sep 6, 2024 |
| ARDX | Ardelyx, Inc. | $11.00 | $6.93 | +58.6% | 2 | Aug 5, 2024 |
| ARCT | Arcturus Therapeutics Holdings Inc. | $8.58 | $8.64 | -0.8% | 1 | Jul 2, 2024 |
| MIRM | Mirum Pharmaceuticals, Inc. | $66.00 | $97.47 | -32.3% | 2 | Jun 17, 2024 |
| AKBA | Akebia Therapeutics, Inc. | $6.00 | $1.41 | +325.5% | 1 | Mar 28, 2024 |
| ABUS | Arbutus Biopharma Corporation | $8.50 | $4.32 | +97.0% | 1 | Mar 17, 2022 |
Recent Activity
- Dec 30, 2024— Set$48.00price target onNAMS(NewAmsterdam Pharma Company N.V.)
- Nov 6, 2024— Set$95.00price target onRARE(Ultragenyx Pharmaceutical Inc.)
- Sep 27, 2024— Set$18.00price target onTVTX(Travere Therapeutics, Inc.)
- Sep 13, 2024— Set$38.00price target onPLRX(Pliant Therapeutics, Inc.)
- Sep 6, 2024— Set$13.00price target onAUPH(Aurinia Pharmaceuticals Inc.)
- Aug 5, 2024— Set$11.00price target onARDX(Ardelyx, Inc.)
- Aug 2, 2024— Set$10.00price target onTVTX(Travere Therapeutics, Inc.)
- Jul 5, 2024— Set$10.00price target onARDX(Ardelyx, Inc.)
- Jul 2, 2024— Set$8.58price target onARCT(Arcturus Therapeutics Holdings Inc.)
- Jun 17, 2024— Set$66.00price target onMIRM(Mirum Pharmaceuticals, Inc.)
- May 7, 2024— Set$36.00price target onPLRX(Pliant Therapeutics, Inc.)
- Apr 24, 2024— Set$9.50price target onTVTX(Travere Therapeutics, Inc.)
- Mar 28, 2024— Set$6.00price target onAKBA(Akebia Therapeutics, Inc.)
- Mar 14, 2024— Set$58.00price target onMIRM(Mirum Pharmaceuticals, Inc.)
- Mar 17, 2022— Set$8.50price target onABUS(Arbutus Biopharma Corporation)
Frequently Asked Questions
Who is Ed Arce?
Ed Arce is a stock analyst at H.C. Wainwright covering 10 stocks primarily in Healthcare. They have issued 15 price targets since Mar 17, 2022.
What stocks does Ed Arce cover?
Ed Arce currently covers 10 stocks, including TVTX, PLRX, ARDX, MIRM, NAMS.
What is Ed Arce's latest price target?
Ed Arce's most recent price target was $48.00 on NAMS (NewAmsterdam Pharma Company N.V.), set on Dec 30, 2024.
What is Ed Arce's highest price target?
Ed Arce's highest issued price target is $95.00 on RARE, set on Nov 6, 2024.
More Analysts at H.C. Wainwright
Coverage based on publicly published price targets. Not investment advice.